Clinical Trial Update: Safety and Efficacy of Propranolol in Newborns With Retinopathy of Prematurity [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating the safety and efficacy of propranolol in newborns with retinopathy of prematurity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinopathy of Prematurity

Drugs mentioned

• Propranolol (propranolol)

Snippet

Sponsor: Meyer Children's Hospital IRCCS | Conditions: Retinopathy of Prematurity | Phase 2, Phase 3 | Status: COMPLETED